Abstract
Objectives: Regular exercise testing, particularly cardiopulmonary exercise testing (CPET), is recommended best practice in the United Kingdom (UK) for people with cystic fibrosis (pwCF), as is providing and regularly reviewing training programmes. This study aimed to ascertain exercise testing and training practices the UK, as well as any barriers/facilitators to implementation, a decade on from the last review.
Methods: An online survey (Qualtrics XM; Provo, Utah, USA) was distributed electronically to healthcare professionals involved in the exercise management of pwCF in the UK via professional networks.
Results: Thirty-one CF centres participated (11 adult, 16 paediatric, 4 combined), 24 of which were specialist, and 7 were networked clinics. Of these, 94% reported using exercise testing (vs. 53% in 2010). The six-minute walk test was the most used exercise test (used in 55% of centres), whilst 48% are using CPET. Exercise testing most commonly occurred at annual review(93%) andwas typically supervised by physiotherapists (62%). Space was the main barrier to exercise testing (31% of centres). For exercise training, all centres discussed this with pwCF (vs. 82% in 2010); with 94% doing so at every clinic appointment. Physiotherapists predominantly undertake these discussions (74%), with staff training and availability cited as common barriers to subsequent implementation of training programmes.
Conclusions: The present data provides a contemporary insight into UK clinical exercise testing and training practice for pwCF, a decade on from when last surveyed. Encouragingly, more clinical exercise testing and exercise counselling appears to be taking place, perhaps reflecting increased understanding of the benefits of exercise across the CF community, as well as recently published guidance. This survey provides evidence with which to standardise further exercise services for pwCF.
Methods: An online survey (Qualtrics XM; Provo, Utah, USA) was distributed electronically to healthcare professionals involved in the exercise management of pwCF in the UK via professional networks.
Results: Thirty-one CF centres participated (11 adult, 16 paediatric, 4 combined), 24 of which were specialist, and 7 were networked clinics. Of these, 94% reported using exercise testing (vs. 53% in 2010). The six-minute walk test was the most used exercise test (used in 55% of centres), whilst 48% are using CPET. Exercise testing most commonly occurred at annual review(93%) andwas typically supervised by physiotherapists (62%). Space was the main barrier to exercise testing (31% of centres). For exercise training, all centres discussed this with pwCF (vs. 82% in 2010); with 94% doing so at every clinic appointment. Physiotherapists predominantly undertake these discussions (74%), with staff training and availability cited as common barriers to subsequent implementation of training programmes.
Conclusions: The present data provides a contemporary insight into UK clinical exercise testing and training practice for pwCF, a decade on from when last surveyed. Encouragingly, more clinical exercise testing and exercise counselling appears to be taking place, perhaps reflecting increased understanding of the benefits of exercise across the CF community, as well as recently published guidance. This survey provides evidence with which to standardise further exercise services for pwCF.
Original language | English |
---|---|
Pages (from-to) | S48-S49 |
Number of pages | 2 |
Journal | Journal of Cystic Fibrosis |
Volume | 21 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - 10 Jun 2022 |
Event | 45th European Cystic Fibrosis Society Conference: Making time for exercise and physical activity - Rotterdam, Netherlands Duration: 8 Jun 2022 → 11 Jun 2022 |